Demonstrates a novel approach to synthesize demethyl-chanoclavine, indicating advances in biocatalysis and synthetic chemistry.
Ergot alkaloids are a structurally complex family of bioactive natural products whose chemical diversification remains challenging. Here we report a concise three-step chemoenzymatic synthesis of the unnatural ergot alkaloid demethyl-chanoclavine, featuring a fused tricyclic indole skeleton with a free amine. The strategy integrates TrpB-catalyzed indole alkylation and a protecting-group-free Pd-catalyzed cross-coupling. Therefore, an efficient engineered EasC-catalyzed decarboxylative cyclization that forges the C5–C10 bond with high efficiency. Computer-aided stability engineering converted EasC into a suitable biocatalyst capable of accepting an unnatural substrate, increasing its catalytic activity by over 15-fold relative to the wild type. The optimized process proceeds under mild conditions. This work demonstrates the power of combining enzyme engineering with modern cross-coupling chemistry to enable efficient access to structurally complex unnatural ergot alkaloids.
No takes yet. Share an insight, caveat, or question.
Gao et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: